CV Sciences (CVSI) Asset Writedowns and Impairment (2016 - 2020)
CV Sciences (CVSI) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with $6.2 million as the latest value for Q4 2020.
- Quarterly Asset Writedowns and Impairment rose 3031.31% to $6.2 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2020, up 2613.56% year-over-year, with the annual reading at $251000.0 for FY2023, 79.66% down from the prior year.
- Asset Writedowns and Impairment hit $6.2 million in Q4 2020 for CV Sciences, up from $198000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $6.2 million in Q4 2020 to a low of -$1000.0 in Q2 2018.
- Historically, Asset Writedowns and Impairment has averaged $874795.2 across 5 years, with a median of $36111.5 in 2018.
- Biggest five-year swings in Asset Writedowns and Impairment: plummeted 100.25% in 2018 and later skyrocketed 9800.0% in 2019.
- Year by year, Asset Writedowns and Impairment stood at $3.5 million in 2016, then tumbled by 97.64% to $82565.0 in 2017, then crashed by 97.58% to $2000.0 in 2018, then surged by 9800.0% to $198000.0 in 2019, then soared by 3031.31% to $6.2 million in 2020.
- Business Quant data shows Asset Writedowns and Impairment for CVSI at $6.2 million in Q4 2020, $198000.0 in Q4 2019, and $6000.0 in Q3 2019.